Millions of people have died of coronavirus infection since 2020 because influential institutions took too long to recognize that it is primarily airborne, and a new University of Colorado Boulder-led historical analysis ...
Sep 2, 2022
3
90
A randomized trial in nearly 4,000 outpatients with COVID-19 has found no benefit of treatment with aspirin or colchicine. The late breaking research was presented in a Hot Line session on 29 August at ESC Congress 2022.
Aug 30, 2022
0
13
A new study of 57 people with mild COVID-19 estimates how long people are infectious for and when they can safely leave isolation.
Aug 19, 2022
0
11
Findings from a new study led by UMass Chan Medical School researchers are the basis for a safety communication issued by the U.S. Food and Drug Administration (FDA) Aug. 11 regarding serial use of at-home antigen tests for ...
Aug 12, 2022
0
10
A model of COVID-19 dynamics in South Africa reveals epidemiological characteristics of the main SARS-CoV-2 variants of concern and highlights their potential to cause further outbreaks. Published in eLife, the researchers' ...
Aug 10, 2022
0
29
Researchers at Stanford University and Emory University have launched a nationwide initiative to monitor monkeypox, COVID-19, and other infectious diseases in communities by measuring viral genetic material in wastewater. ...
Aug 8, 2022
0
25
The omicron subvariant known as BA.5 was first detected in South Africa in February 2022 and spread rapidly throughout the world. As of the second week of July 2022, BA.5 constituted nearly 80% of COVID-19 variants in the ...
Jul 27, 2022
0
3
Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in Proceedings of the National ...
Jul 25, 2022
0
138
Recent acute hepatitis cases of unknown origin in children have now been linked to the virus AAV2 in two new U.K. studies, with no evidence of a direct link to SARS-CoV-2 infection.
Jul 25, 2022
0
29
As part of ongoing efforts to make a live attenuated vaccine for COVID-19, Texas Biomedical Research Institute Professor Luis Martinez-Sobrido and his team developed a weakened, or attenuated, version of SARS-CoV-2 that does ...
Jul 21, 2022
0
7
